Basics Soleno Therapeutics, Inc. Common Stock Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. IPO Date: November 10, 2014 Sector: Healthcare Industry: Biotech Market Cap: $3.81B Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 3.71% Avg Daily Range (30 D): $1.14 | 1.52% Avg Daily Range (90 D): $1.34 | 2.18% Institutional Daily Volume Avg Daily Volume: .55M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): .94M Trade Size Avg Trade Size (Sh.): 182 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 1,345 Avg Inst. Trade: $2.29M Avg Inst. Trade (30 D): $3.26M Avg Inst. Trade (90 D): $2.53M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $3.65M Avg Closing Trade (30 D): $6.37M Avg Closing Trade (90 D): $5.25M Avg Closing Volume: 73.59K     News May 22, 2025 @ 9:32 PM Soleno Therapeutics Announces Submission and EMA V... Source: N/A Feb 21, 2025 @ 6:00 PM Evolving Landscape of Obesity: Key Market Insights... Source: Delveinsight Nov 27, 2024 @ 1:00 PM Soleno Therapeutics to Participate in Piper Sandle... Source: Na Jul 20, 2024 @ 2:42 AM Soleno Therapeutics enters agreement to sell $150 ... Source: Investing.Com Jul 3, 2024 @ 10:16 PM Soleno therapeutics exec sells over $90k in stock ... Source: Investing.Com Financials   TTM Q1 2025 Q4 2024 Basic EPS $-4.65 $-.95 $-1.3 Diluted EPS $-4.65 $-.95 $-1.3 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -198.23M $ -43.77M $ -55.98M Operating Income / Loss $ -209.94M $ -45.74M $ -59.12M Cost of Revenue $ $ $ Net Cash Flow $ 38.48M $ -6.6M $ 39.52M PE Ratio     Splits Aug 26, 2022:   1:15 Oct 06, 2017:   1:5